Phreesia, Inc. (NYSE:PHR) Given Average Recommendation of "Buy" by Analysts

Shares of Phreesia, Inc. (NYSE:PHR - Get Free Report) have been given a consensus recommendation of "Buy" by the twelve brokerages that are presently covering the firm, MarketBeat reports. Twelve equities research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $31.33.

Several equities analysts have recently weighed in on PHR shares. Canaccord Genuity Group raised their price objective on Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a report on Thursday, March 13th. DA Davidson reduced their price target on Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a research report on Monday, April 14th. Wall Street Zen lowered Phreesia from a "buy" rating to a "hold" rating in a research report on Saturday. Needham & Company LLC reiterated a "buy" rating and set a $29.00 price objective on shares of Phreesia in a research note on Thursday, March 13th. Finally, Piper Sandler reissued an "overweight" rating and issued a $33.00 price objective (up previously from $31.00) on shares of Phreesia in a report on Wednesday, January 29th.

Phreesia Stock Down 1.1%

PHR stock traded down $0.27 during midday trading on Wednesday, hitting $24.07. The company's stock had a trading volume of 242,602 shares, compared to its average volume of 439,105. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74. Phreesia has a twelve month low of $17.07 and a twelve month high of $30.53. The company's fifty day moving average price is $25.08 and its 200 day moving average price is $25.24. The stock has a market capitalization of $1.43 billion, a P/E ratio of -16.37 and a beta of 0.74.

Insider Transactions at Phreesia

In other news, SVP David Linetsky sold 4,499 shares of the firm's stock in a transaction dated Wednesday, April 16th. The shares were sold at an average price of $23.73, for a total transaction of $106,761.27. Following the completion of the sale, the senior vice president now owns 217,239 shares in the company, valued at approximately $5,155,081.47. This trade represents a 2.03% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, General Counsel Allison C. Hoffman sold 3,496 shares of Phreesia stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $25.32, for a total transaction of $88,518.72. Following the sale, the general counsel now directly owns 139,134 shares of the company's stock, valued at $3,522,872.88. The trade was a 2.45% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 42,474 shares of company stock worth $1,023,208. 5.80% of the stock is owned by company insiders.

Institutional Investors Weigh In On Phreesia

A number of institutional investors have recently made changes to their positions in the company. Invesco Ltd. increased its stake in shares of Phreesia by 0.9% during the fourth quarter. Invesco Ltd. now owns 40,249 shares of the company's stock worth $1,013,000 after purchasing an additional 357 shares during the period. NewEdge Advisors LLC increased its position in Phreesia by 12.1% during the 4th quarter. NewEdge Advisors LLC now owns 4,256 shares of the company's stock worth $107,000 after buying an additional 459 shares during the period. Arcadia Investment Management Corp MI increased its position in Phreesia by 0.7% during the 1st quarter. Arcadia Investment Management Corp MI now owns 92,770 shares of the company's stock worth $2,371,000 after buying an additional 615 shares during the period. QRG Capital Management Inc. lifted its holdings in shares of Phreesia by 8.0% during the first quarter. QRG Capital Management Inc. now owns 11,118 shares of the company's stock worth $284,000 after buying an additional 827 shares in the last quarter. Finally, Johnson Financial Group Inc. lifted its holdings in shares of Phreesia by 381.3% during the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock worth $28,000 after buying an additional 896 shares in the last quarter. Institutional investors own 92.10% of the company's stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.